102467-02-7Relevant academic research and scientific papers
Substituted isothiazolones
-
Page/Page column 25, (2010/11/25)
This invention is directed to a compound of Formula (I): and pharmaceutically acceptable forms thereof useful as inhibitors of cPLA2 and a method for preventing, treating or ameliorating a cPLA2 mediated inflammatory related disease, disorder or condition using a compound of Formula (I) and, more particularly, for preventing, treating or ameliorating a cPLA2 mediated inflammatory related disease, disorder or condition which results from the cellular secretion of TXB2 or LTB4.
